Quintrio
Home

PHARMACEUTICAL PREPARATIONS

Braveheart Bio, Inc. Common Stock

BRVE

Braveheart Bio Inc is a clinical-stage biotechnology company focused on developing therapeutics to treat hypertrophic cardiomyopathy (HCM) and other cardiovascular diseases. Its flagship product candidate, BHB-1893, is an oral small-molecule cardiac myosin inhibitor being developed for the treatment of obstructive HCM (oHCM) and non-obstructive HCM (nHCM).

Last trade $18.46
Day change -$1.03 (-5.28%)
Day range $17.94 – $19.50
Volume 676,973
Market cap $1.75B

Open XNAS

Fundamentals

Key company ratios and reported financial statements.

Source: Massive.com

Key ratios

No ratio data was found for BRVE.

Financial statements

Income and cash flow amounts are for the period; balance sheets are point-in-time snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are displayed when available.

Income statement for BRVE, quarterly periods
Line itemQ3 FY2026 Sep 30, 2026
Revenue$0
Cost of revenue$0
Gross profit$0
Selling, general and administrative$12.61M
Research and development$17.54M
Total operating expenses$30.15M
Operating income-$30.15M
Interest expense$0
Income before taxes-$26.5M
Income taxes$0
Net income-$26.5M
Net income attributable to common shareholders-$26.5M
EBITDA-$30.15M
Basic earnings per share-$0.51
Diluted earnings per share-$0.51

Recent news

Company coverage with links to the original publishers.

Publication times in UTC
The Motley Fool

Braveheart Bio Chairman Chris Viehbacher Buys $1.5M Shares at IPO. What Does This Mean for Investors?

Braveheart Bio Chairman Chris Viehbacher purchased 83,333 shares worth $1.5 million at the company's IPO price of $18 per share on August 7, 2026, expanding his direct stake by 16%. The insider purchase, combined with strong IPO demand and positive Phase 2 trial results for the company's lead cardiac myosin inhibitor candidate, signals bullishness around the clinical-stage biotech company.

Dividends

Declared distributions and recorded event dates. Forecasts are not shown.

Updated daily

No declared upcoming dividend found.

No prior dividend records found.

Stock splits

Historical share-structure events and their execution dates.

Updated daily

No stock split records found.